In REDEFINE 1 (overweight/obesity without T2D), CagriSema achieved mean weight reductions of 20.4-22.7% (vs 2.3-3.0% placebo) at 68 weeks, with 53.6% and 34.7% of patients achieving 20% and 25% weight loss, respectively
Record assay-matrix context when relevant When workflows are sensitive, record key features of the assay environment that can influence effective exposure, such as buffer identity and staging steps
We're honest that results take months, not weeks
Reduction in Hyperpigmentation This treatment is often used to help improve the appearance of dark spots, acne marks, and uneven skin tone
PharmaLabGlobal offers additional pre-mixed cartridges so you can carry on with your scientific investigation, as well as additional peptide research supplies
Millam, J